Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bivalirudin vs Heparin in LAAO for NVAF
NCT04195997Phase 4Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Feb 2020
- Primary completion
- Dec 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bivalirudin in Atrial fibrillation (AFib), sponsored by Zhongshan Hospital, Fudan University. Status: unknown.
02
Drugs
bivalirudin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04195997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04195997.